These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 22076509)

  • 1. Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.
    Grskovic M; Javaherian A; Strulovici B; Daley GQ
    Nat Rev Drug Discov; 2011 Nov; 10(12):915-29. PubMed ID: 22076509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells as in vitro model of Parkinson's disease.
    Martínez-Morales PL; Liste I
    Stem Cells Int; 2012; 2012():980941. PubMed ID: 22619684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New lessons learned from disease modeling with induced pluripotent stem cells.
    Onder TT; Daley GQ
    Curr Opin Genet Dev; 2012 Oct; 22(5):500-8. PubMed ID: 22749051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
    Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
    Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSC technology: platform for drug discovery. Point.
    Ellis J; Bhatia M
    Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine.
    Silva MC; Haggarty SJ
    Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.
    Xu XH; Zhong Z
    Acta Pharmacol Sin; 2013 Jun; 34(6):755-64. PubMed ID: 23685955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
    Costamagna G; Comi GP; Corti S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
    Ye L; Ni X; Zhao ZA; Lei W; Hu S
    J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: drug discovery in the age of the induced pluripotent stem cell.
    Ko HC; Gelb BD
    Stem Cells Transl Med; 2014 Apr; 3(4):500-9. PubMed ID: 24493856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
    Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel stem cell-based drug discovery platforms for cardiovascular disease.
    Adams WJ; García-Cardeña G
    J Biomol Screen; 2012 Oct; 17(9):1117-27. PubMed ID: 22853930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery.
    Zhang R; Zhang LH; Xie X
    Acta Pharmacol Sin; 2013 Jun; 34(6):765-76. PubMed ID: 23603980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.
    Sharlow ER; Koseoglu MM; Bloom GS; Lazo JS
    Assay Drug Dev Technol; 2020; 18(2):97-103. PubMed ID: 31095406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.